KG

Koteswararao Gangisetty

Active Director Director DIN 09586361
DIN 09586361 First appointment Apr 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value •••• Premium profile

About Koteswararao Gangisetty

Data last updated:

Koteswararao Gangisetty is a Director at Elamus Pharmaceuticals Private Limited (since 2022). The company operates in Pharma. Elamus Pharmaceuticals Private Limited reported revenue of ₹4.58 Cr (FY 2025).

DIN 09586361
Primary Designation Director
Industry Pharma
First Appointment 26 Apr 2022
Oldest Company Age 4 yrs
Largest company Elamus Pharmaceuticals Private Limited · ₹4.58 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Apr 20222022₹4.58 Cr (FY 2025)Active

Board colleagues of Koteswararao Gangisetty

NameDINCompanyDesignation
Aruna Gangisetty09756715Elamus Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Elamus Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Koteswararao Gangisetty

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Koteswararao Gangisetty

Koteswararao Gangisetty currently holds 1 directorship: Elamus Pharmaceuticals Private Limited (Director, since 26 Apr 2022, revenue ₹4.58 Cr (FY 2025)).

Koteswararao Gangisetty was first appointed on 26 Apr 2022 as Director at Elamus Pharmaceuticals Private Limited.

The current boards of Koteswararao Gangisetty's companies include Aruna Gangisetty (Elamus Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available